The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas‐related symptoms and their impact on daily life among general population and irritable bowel syndrome. Issue 3 (18th June 2021)
- Record Type:
- Journal Article
- Title:
- The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas‐related symptoms and their impact on daily life among general population and irritable bowel syndrome. Issue 3 (18th June 2021)
- Main Title:
- The Intestinal Gas Questionnaire (IGQ): Psychometric validation of a new instrument for measuring gas‐related symptoms and their impact on daily life among general population and irritable bowel syndrome
- Authors:
- Duracinsky, Martin
Archbold, Sharon
Lobo, Beatriz
Bessonneau, Pascal
Thonon, Frédérique
Santos, Javier
Guagnozzi, Danila
Payakachat, Nalin
Coffin, Benoit
Azpiroz, Fernando
Whorwell, Peter J.
Chassany, Olivier - Abstract:
- Abstract: Background: Gas‐related symptoms (GRS) are common in the general population (GPop) and among patients with disorders of gut‐brain interactions but there is no patient‐reported outcome evaluating these symptoms and their impact on daily life. We have previously developed a 43‐item intestinal gas questionnaire (IGQ). The aim of the present study is to perform a psychometric validation of this instrument. Methods: Participants (119 from the GPop and 186 irritable bowel syndrome (IBS) patients) were recruited from 3 countries (UK, Spain, France). IBS patients fulfilled ROME IV criteria with an IBS severity score between 150 and 300. Participants completed the IGQ, the functional Digestive Disorders Quality of Life (FDDQL), and the EQ‐5D. A subgroup ( n = 90) repeated the IGQ completion after 7 days on paper or electronically. Results: From the original IGQ questionnaire, 26 items were deleted because of poor performance. Confirmatory factorial analysis on the remaining 17 items (7 symptom and 10 impact items) yielded a 6‐factor structure accounting for 67% of the variance for bloating (6 items), flatulence (3), belching (2), bad breath (2), stomach rumbling (2), and difficult gas evacuation (2). Global score (0‐100) was worse among IBS vs GPop (40 ± 15 vs 33 ± 17; p = 0.0016). At the second visit, the intraclass correlation coefficient of IGQ scores was between 0.71 and 0.86 ( n = 67) for test‐retest reliability and 0.61‐0.87 ( n = 64) for equivalence betweenAbstract: Background: Gas‐related symptoms (GRS) are common in the general population (GPop) and among patients with disorders of gut‐brain interactions but there is no patient‐reported outcome evaluating these symptoms and their impact on daily life. We have previously developed a 43‐item intestinal gas questionnaire (IGQ). The aim of the present study is to perform a psychometric validation of this instrument. Methods: Participants (119 from the GPop and 186 irritable bowel syndrome (IBS) patients) were recruited from 3 countries (UK, Spain, France). IBS patients fulfilled ROME IV criteria with an IBS severity score between 150 and 300. Participants completed the IGQ, the functional Digestive Disorders Quality of Life (FDDQL), and the EQ‐5D. A subgroup ( n = 90) repeated the IGQ completion after 7 days on paper or electronically. Results: From the original IGQ questionnaire, 26 items were deleted because of poor performance. Confirmatory factorial analysis on the remaining 17 items (7 symptom and 10 impact items) yielded a 6‐factor structure accounting for 67% of the variance for bloating (6 items), flatulence (3), belching (2), bad breath (2), stomach rumbling (2), and difficult gas evacuation (2). Global score (0‐100) was worse among IBS vs GPop (40 ± 15 vs 33 ± 17; p = 0.0016). At the second visit, the intraclass correlation coefficient of IGQ scores was between 0.71 and 0.86 ( n = 67) for test‐retest reliability and 0.61‐0.87 ( n = 64) for equivalence between electronic and paper versions of IGQ. Conclusion: The IGQ available in paper and electronic versions in 3 languages is a robust instrument for capturing and measuring GRS and their impact on daily life. Abstract : Intestinal Gas Quesitonnaire (IGQ): a new tool to measure Gas‐Related Symptoms and their impact on daily life. … (more)
- Is Part Of:
- Neurogastroenterology & motility. Volume 34:Issue 3(2022)
- Journal:
- Neurogastroenterology & motility
- Issue:
- Volume 34:Issue 3(2022)
- Issue Display:
- Volume 34, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 34
- Issue:
- 3
- Issue Sort Value:
- 2022-0034-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-06-18
- Subjects:
- gas‐related symptoms -- general population -- IBS -- patient‐reported outcomes -- psychometrics -- quality of life
Gastrointestinal system -- Motility -- Periodicals
Gastrointestinal system -- Innervation -- Periodicals
616.33 - Journal URLs:
- http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=nmo ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2982 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/nmo.14202 ↗
- Languages:
- English
- ISSNs:
- 1350-1925
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.371450
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 27062.xml